Tocilizumab or glucocorticoids treatment for patients with SARS-CoV-2 pneumonia: An observational study

Objective: To estimate the effect of tocilizumab or glucocorticoids in preventing death and intubation in patients hospitalized with SARS-CoV-2 pneumonia. Methods: This was a retrospective cohort study enrolling all consecutive patients hospitalized at Reggio Emilia AUSL between February the 11th an...

Full description

Bibliographic Details
Published in:	Brazilian Journal of Infectious Diseases
Main Authors:	Giovanni Dolci, Giulia Cassone, Giulia Besutti, Romina Corsini, Fabio Sampaolesi, Valentina Iotti, Elena Galli, Adalgisa Palermo, Matteo Fontana, Pamela Mancuso
Format:	Article
Language:	English
Published:	Elsevier 2022-01-01
Subjects:	COVID-19 SARS-CoV-2 Tocilizumab Glucocorticoids Methylprednisolone Corticosteroids
Online Access:	http://www.sciencedirect.com/science/article/pii/S1413867021001719

Similar Items

Glucocorticoid boluses followed by tocilizumab in giant cell arteritis patients: effects on peripheral blood monocytes and lymphocytes
by: Cecilia Catellani, et al.
Published: (2025-03-01)

Do All Critically Ill Patients with COVID-19 Disease Benefit from Adding Tocilizumab to Glucocorticoids? A Retrospective Cohort Study
by: Cristina Mussini, et al.
Published: (2023-01-01)

Comparing the Effect of Tocilizumab and Methylprednisolone Pulse on Mortality and Outcomes in Patients with Severe COVID-19 in Bushehr
by: Razeah Rastegar, et al.
Published: (2024-05-01)

Success Treatment of Severe and Active Graves’ Orbitopathy with Tocilizumab After Thyroidectomy and Maximum Dose of Intravenous Methylprednisolone
by: Laurentius Aswin Pramono
Published: (2024-01-01)

Success Treatment of Severe and Active Graves’ Orbitopathy with Tocilizumab After Thyroidectomy and Maximum Dose of Intravenous Methylprednisolone
by: Laurentius Aswin Pramono
Published: (2023-10-01)

Radiological and inflammatory outcome in severe covid-19 patients received tocilizumab versus high dose of methylprednisolone
by: Asmaa kamel, et al.
Published: (2022-10-01)

Serum proteomics in giant cell arteritis in response to a three-day pulse of glucocorticoid followed by tocilizumab monotherapy (the GUSTO trial)
by: Lisa Christ, et al.
Published: (2023-05-01)

Glucocorticoid for croup in children
by: Jeffrey Hom, et al.
Published: (2020-08-01)

Dysthyroid optic neuropathy treated with tocilizumab
by: Yuerong Yan, et al.
Published: (2025-02-01)

Metabolic effects of high-dose glucocorticoid following out-of-hospital cardiac arrest
by: Rasmus Paulin Beske, et al.
Published: (2025-04-01)

Early identification of COVID-19 cytokine storm and treatment with anakinra or tocilizumab
by: Annette Langer-Gould, et al.
Published: (2020-10-01)

Local Glucocorticoids in Treatment of Children with Dermatitis
by: Yliya G. Levina, et al.
Published: (2020-01-01)

A Pilot Study on Tocilizumab in Very-Late-Onset Myasthenia Gravis
by: Yang TT, et al.
Published: (2023-12-01)

The Meteoritics Trial: efficacy of methotrexate after remission-induction with tocilizumab and glucocorticoids in giant cell arteritis—study protocol for a randomized, double-blind, placebo-controlled, parallel-group phase II study
by: Lena Kreis, et al.
Published: (2024-01-01)

Early C-reactive protein reduction predicts survival in COVID-19 severe pneumonia treated with glucocorticoids
by: Nicolò Reccardini, et al.
Published: (2025-09-01)

A systematic review and meta-analysis of glucocorticoids treatment in severe COVID-19: methylprednisolone versus dexamethasone
by: Shukun Hong, et al.
Published: (2023-05-01)

Active withdrawal of corticosteroids using tocilizumab and its association with autoantibody profiles in relapsed Takayasu arteritis: a multicentre, single-arm, prospective study (the Ab-TAK study)
by: Tsuyoshi Shirai, et al.
Published: (2025-01-01)

Glucocorticoids Directly Affect Hyaluronan Production of Orbital Fibroblasts; A Potential Pleiotropic Effect in Graves’ Orbitopathy
by: Erika Galgoczi, et al.
Published: (2022-12-01)

Efectividad y seguridad de tocilizumab en 2 casos de orbitopatía tiroidea grave refractaria a corticosteroides. Hospital San José, Bogotá
by: A. Sierra Osorio, et al.
Published: (2021-06-01)

A Bibliometric Analysis of Publications on Spinal Cord Injury Treatment With Glucocorticoids Using VOSviewer
by: Yu Zhang, et al.
Published: (2022-08-01)

Revisiting the question of the safety of glucocorticoids use of in the treatment of rheumatoid arthritis
by: E. A. Aronova, et al.
Published: (2023-07-01)

An update of the Malaysian Clinical Guidance on the management of glucocorticoid-induced osteoporosis, 2015
by: Swan Sim Yeap, et al.
Published: (2017-03-01)

Genetic variability in the glucocorticoid pathway and treatment outcomes in hospitalized patients with COVID-19: a pilot study
by: Patricija Štampar, et al.
Published: (2024-07-01)

Use of Corticosteroids in Coronavirus Disease 2019 Pneumonia: A Systematic Review of the Literature
by: Nicola Veronese, et al.
Published: (2020-04-01)

Vision loss in patients with giant cell arteritis treated with tocilizumab
by: Jennifer Amsler, et al.
Published: (2021-03-01)

Morphogenic Effect of Exogenous Glucocorticoid Hormones in the <i>Girardia tigrina</i> Planarian (<i>Turbellaria</i>, <i>Tricladida</i>)
by: Artem Ermakov, et al.
Published: (2023-02-01)

Modulation by Ozone of Glucocorticoid-Regulating Factors in the Lungs in Relation to Stress Axis Reactivity
by: Jith Thomas, et al.
Published: (2021-11-01)

Predictive factors of clinical outcomes in patients with COVID-19 treated with tocilizumab: A monocentric retrospective analysis
by: Giulia Cassone, et al.
Published: (2022-01-01)

Anti-inflammatory drugs in COVID-19
by: Mohamed Elnady
Published: (2021-01-01)

Association of cumulative methylprednisolone dosages with mortality risk from pneumonia in connective tissue disease patients
by: Saibin Wang, et al.
Published: (2024-11-01)

Tocilizumab: A potent immunomodulatory agent in the treatment of COVID-19 pneumonia
by: Sameer Bansal, et al.
Published: (2021-01-01)

Relapses of pain syndrome in patients with polymyalgia rheumatica during reduction of glucocorticoid therapy
by: N. V. Bunchuk
Published: (2023-02-01)

Use of corticosteroids in the therapy of COVID-19 infection (corticosteroids in COVID-19 infection)
by: Milenković Marija, et al.
Published: (2021-01-01)

Steroid-sparing strategies in polymyalgia rheumatica: a systematic review and meta-analysis of tocilizumab with practical guidance for tapering
by: Musa Khan Bungish, et al.
Published: (2026-04-01)

The Effects of Immunosuppressive Therapy on Mortality in Patients Followed in Intensive Care Units with the Diagnosis of Critical Coronavirus Disease-2019 Pneumonia
by: Ömer Ayten, et al.
Published: (2022-05-01)

Glucocorticoid regulation of cancer development and progression
by: Stuti Khadka, et al.
Published: (2023-04-01)

Cepharanthine synergistically promotes methylprednisolone pharmacodynamics against human peripheral blood mononuclear cells possibly via regulation of P-glycoprotein/glucocorticoid receptor translocation
by: Wencheng Xu, et al.
Published: (2024-05-01)

Successful high-dose glucocorticoid therapy for anti-mitochondrial antibody-positive myocarditis arising during tocilizumab and low-dose glucocorticoid therapy for rheumatoid arthritis
by: Koji Suzuki, et al.
Published: (2024-07-01)

Glucocorticoid attenuates acute lung injury through induction of type 2 macrophage
by: Guo-wei Tu, et al.
Published: (2017-08-01)

Perinatal glucocorticoid sensitivity in the preterm newborn: molecular mechanisms, endogenous determinants, and clinical implications
by: Nana A. O. Anti, et al.
Published: (2025-07-01)